  See all
 |
Articles: Dosing |
Prior Articles
A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for second-line or greater treatment of selected advanced solid tumors
Anti-Cancer Drugs, 07/02/09
Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder
The Journal of Pediatrics, 07/01/09 Transdermal Nitroglycerin Therapy May Not Prevent Early Postmenopausal Bone Loss
Journal of Clinical Endocrinology and Metabolism, 07/01/09
Exclusive Author Commentary Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy
Current Medical Research and Opinion, 07/01/09 Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada
Current Medical Research and Opinion, 07/01/09 Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects
Current Medical Research and Opinion, 07/01/09 Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
Gynecologic Oncology, 06/30/09 Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: Effects on nasal congestion
Allergy and Asthma Proceedings, 06/30/09 High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases
Clinical Reviews in Allergy and Immunology, 06/30/09 Increasing womens choices in medical abortion: A study of misoprostol 400 ug swallowed immediately or held sublingually following 200 mg mifepristone
The European Journal of Contraception & Reproductive Health Care, 06/30/09 Genetic and clinical factors relating to warfarin dosing
Trends in Pharmacological Sciences, 06/30/09 Interval of Injections of Intramuscular Depot Medroxyprogesterone Acetate in the Long-Term Treatment of Endometriosis-Associated Pain: A Randomized Comparative Trial
Gynecologic and Obstetric Investigation, 06/29/09 Effectiveness of fluticasone furoate 110 micro g once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen
Current Medical Research and Opinion, 06/26/09 Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer
Annals of Oncology, 06/26/09 A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies
Clinical Cancer Research, 06/25/09 A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression
Journal of Acquired Immune Deficiency Syndromes, 06/25/09 Do PPIs and H2-blockers increase the risk of hip fractures
American Pharmacists Association, 06/25/09
Free full text
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis
BJU International, 06/24/09 Treatment of Disseminated Granuloma Annulare with Low-dose Fumaric Acid
Acta Dermato-Venereologica, 06/24/09 Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily
Cancer, 06/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
